NCT06235619 Arch Size Study for Anatomical Variations
| NCT ID | NCT06235619 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS San Raffaele |
| Condition | Aortic Arch |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2024-09-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2024-09-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aortic arch with a common origin of the innominate and left carotid artery (CILCA) prevalence in the general population is 13.6%. Its reputation as a benign anatomical variant has been ultimately shattered by further studies that identified the CILCA arch as a potential marker for thoracic aortic disease (TAD) The aim of this work is to report the CT anatomical characteristics of the aortic arch in subjects with or without aneurysms requiring treatment, in 5 major European cardiovascular centers.
Eligibility Criteria
Inclusion Criteria: all patients with aortic arch CT scan at investigating centers Exclusion Criteria: none
Frequently Asked Questions
Who can join the NCT06235619 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, up to 100 Years, studying Aortic Arch. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06235619 currently recruiting?
Yes, NCT06235619 is actively recruiting participants. Visit ClinicalTrials.gov or contact IRCCS San Raffaele to inquire about joining.
Where is the NCT06235619 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06235619 clinical trial?
NCT06235619 is sponsored by IRCCS San Raffaele. The trial plans to enroll 500 participants.